Effect of β3-adrenoceptor agonist on the micromotion of bilateral major pelvic ganglion-excised rat bladder

被引:1
|
作者
Son, Hee Seo [1 ,2 ]
Moon, Soo Young [3 ]
Kwon, Joonbeom [4 ]
Kim, Jang Hwan [1 ,2 ,5 ,6 ]
机构
[1] Yonsei Univ, Severance Hosp, Coll Med, Dept Urol, Seoul, South Korea
[2] Yonsei Univ, Severance Hosp, Urol Sci Inst, Coll Med, Seoul, South Korea
[3] Korea Univ, Biomed Res Ctr, Ansan Hosp, Ansan, South Korea
[4] Daegu Fatima Hosp, Dept Urol, Daegu, South Korea
[5] Yonsei Univ, Coll Med, Dept Urol, 50-1 Yonsei Ro, Seoul 03722, South Korea
[6] Yonsei Univ, Urol Sci Inst, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
关键词
beta 3-adrenoceptor agonist; major pelvic ganglion; micromotions; models; animal; neurons; afferent; overactive bladder; urinary bladder; NON-VOIDING ACTIVITY; BETA(3)-ADRENOCEPTOR AGONIST; DETRUSOR OVERACTIVITY; AFFERENT ACTIVITY; URINARY; PATHOPHYSIOLOGY; DYSFUNCTION; MODULATION; MIRABEGRON;
D O I
10.1002/nau.25127
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aims Micromotion is an autonomous intramural movement of the bladder, and is believed to be an initial step in the generation of urinary urgency. Therefore, controlling micromotion may be a novel target in overactive bladder (OAB) treatment. However, developing micromotion treatment has been limited by the absence of a standardized animal model. We attempted to create a micromotion animal model and investigated the effectiveness of a beta(3)-adrenoceptor agonist (CL316,243) on micromotion.Methods Bilateral major pelvic ganglia (MPGs) were excised in 18 male Sprague-Dawley rats, resulting in an almost completely denervated bladder. On postoperative Day 7, cystometry was performed. Rats were divided into three treatment groups: CL316,243; beta(3-)adrenoceptor antagonist (SR59230A) pretreated CL316,243; and a nonselective antimuscarinic agent (oxybutynin). Changes in micromotion were evaluated after the intra-arterial administration of each agent.Results Low-amplitude oscillations in intravesical pressure (micromotion) were observed 1 week after MPGs excision. Micromotion frequency significantly (p = 0.003) decreased (2.17 & PLUSMN; 3.54 times/5 min) with CL316,243 compared with vehicle (6.33 & PLUSMN; 1.97 times/5 min). Micromotion amplitude also decreased with CL316,243 (1.15 & PLUSMN; 1.93 cmH(2)O) compared with vehicle (5.96 & PLUSMN; 5.12 cmH(2)O), approaching conventional significance (p = 0.090). No significant decreases in frequency or amplitude were observed with oxybutynin treatment.Conclusions Systemic administration of the beta(3)-adrenoceptor agonist CL316,243 effectively controlled micromotion in bilateral MPGs-excised, almost completely denervated rat bladders. This result indicates that beta(3)-adrenoceptor agonist may affect the bladder directly, suggesting that it might be effective for overall OAB, regardless of the presence or level of neurological deficits. Bilateral MPGs-excised rats are considered a plausible micromotion animal model suitable for future research.
引用
收藏
页码:530 / 538
页数:9
相关论文
共 50 条
  • [1] Protective Effect of a β3-Adrenoceptor Agonist on Bladder Function in a Rat Model of Chronic Bladder Ischemia
    Sawada, Norifumi
    Nomiya, Masanori
    Hood, Brandy
    Koslov, David
    Zarifpour, Mona
    Andersson, Karl-Erik
    EUROPEAN UROLOGY, 2013, 64 (04) : 664 - 671
  • [2] The expression of β3-adrenoceptor and muscarinic type 3 receptor immuno-reactivity in the major pelvic ganglion of the rat
    J. Eastham
    C. Stephenson
    K. Korstanje
    J. I. Gillespie
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2015, 388 : 695 - 708
  • [3] The expression of β3-adrenoceptor and muscarinic type 3 receptor immuno-reactivity in the major pelvic ganglion of the rat
    Eastham, J.
    Stephenson, C.
    Korstanje, K.
    Gillespie, J. I.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2015, 388 (07) : 695 - 708
  • [4] THE EFFECT OF BETA-3 ADRENERGIC RECEPTOR AGONIST ON MICROMOTIONS OF MAJOR PELVIC GANGLION DISCONNECTED RAT BLADDER
    Son, Hee Seo
    Moon, Soo Young
    Ahn, Hyun Kyu
    Oh, Kyung Taek
    Park, Jee Soo
    Ha, Jee Soo
    Kim, Jang Hwan
    JOURNAL OF UROLOGY, 2018, 199 (04): : E502 - E503
  • [5] A NOVEL β3-ADRENOCEPTOR AGONIST MIRABEGRON FOR OVERACTIVE BLADDER SYMPTOMS
    Okada, Hiroshi
    Sato, Ryo
    Nishio, Kojiro
    Kawaguchi, Makoto
    Soh, Shigehiro
    Arai, Gaku
    JOURNAL OF UROLOGY, 2013, 189 (04): : E564 - E564
  • [6] An aryloxypropanolamine hβ3-adrenoceptor agonist as bladder smooth muscle relaxant
    Tasler, Stefan
    Baumgartner, Roland
    Behr-Roussel, Delphine
    Oger-Roussel, Stephanie
    Gorny, Diane
    Giuliano, Francois
    Ney, Peter
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 46 (05) : 381 - 387
  • [7] Effect of mirabegron, a novel β3-adrenoceptor agonist, on bladder function during storage phase in rats
    Toshiki Hatanaka
    Masashi Ukai
    Mai Watanabe
    Akiyoshi Someya
    Akiyoshi Ohtake
    Masanori Suzuki
    Koji Ueshima
    Shuichi Sato
    Seiji Kaku
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2013, 386 : 71 - 78
  • [8] Effect of mirabegron, a novel β3-adrenoceptor agonist, on bladder function during storage phase in rats
    Hatanaka, Toshiki
    Ukai, Masashi
    Watanabe, Mai
    Someya, Akiyoshi
    Ohtake, Akiyoshi
    Suzuki, Masanori
    Ueshima, Koji
    Sato, Shuichi
    Kaku, Seiji
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2013, 386 (01) : 71 - 78
  • [9] Effects of β3-adrenoceptor agonist on acute urinary retention in a rat model
    Tae Il Noh
    Ji Sung Shim
    Sung Gu Kang
    Seok Ho Kang
    Jun Cheon
    Jeong Gu Lee
    World Journal of Urology, 2021, 39 : 4427 - 4433
  • [10] Effects of β3-adrenoceptor agonist on acute urinary retention in a rat model
    Noh, Tae Il
    Shim, Ji Sung
    Kang, Sung Gu
    Kang, Seok Ho
    Cheon, Jun
    Lee, Jeong Gu
    WORLD JOURNAL OF UROLOGY, 2021, 39 (12) : 4427 - 4433